Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,625,227
+$378,939 QoQ
Shares Held
1,355
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#2,694
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Solstein Capital, LLC holds $2,332,481 across 10 Drug Manufacturers - General names. LLY ranks #1 (69.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,355 | $1,625,227 | |
| 2 | ABBV |
AbbVie Inc.
|
1,110 | $279,320 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,036 | $130,888 | |
| 4 | PFE |
Pfizer Inc
|
2,903 | $69,904 | |
| 5 | JNJ |
Johnson & Johnson
|
234 | $59,428 | |
| 6 | AMGN |
Amgen Inc
|
133 | $48,161 | |
| 7 | NVS |
Novartis AG
|
300 | $47,016 | |
| 8 | NVO |
Novo Nordisk A S
|
794 | $38,064 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,625,227 | 1,355 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,246,288 | 1,355 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,617,393 | 1,505 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,156,708 | 1,516 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,181,767 | 1,516 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,136,452 | 1,376 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,124,032 | 1,456 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,289,928 | 1,456 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,402,433 | 1,549 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,262,629 | 1,623 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $952,491 | 1,634 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $877,670 | 1,634 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $766,313 | 1,634 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $535,735 | 1,560 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $781,068 | 2,135 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $466,917 | 1,444 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $468,188 | 1,444 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $413,518 | 1,444 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $216,280 | 783 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $209,100 | 905 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $207,715 | 905 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $70,057 | 375 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $47,218 | 319 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $52,373 | 319 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $44,251 | 319 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||